Alkotinib Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib

NCT04211922 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor R\&D Strategy Adjustment

Conditions

ALK-positive Non-small Cell Lung Cancer

Interventions

DRUG: Alkotinib Capsules

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd